BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2016
View Archived Issues
FF-21101 enters phase I trials for the treatment of solid tumors
Read More
Geron announces the initiation of phase II/III study of imetelstat in patients with MDS
Read More
Hutchison MediPharma initiates phase I trial of HMPL-523 in hematological malignancies
Read More
FDA will not take action on the NDA for Sustol by the planned PDUFA date
Read More
EMA grants orphan drug designation to LOXO-101 for treatment of soft tissue sarcoma
Read More
Spherium Biomed announces start of phase I trial to evaluate efficacy of SP-12006
Read More
NIH analysis identifies three genes that contribute to primary open-angle glaucoma
Read More
Roche and BioFocus present novel radiotracers for imaging alpha-synuclein
Read More
Novel vaccine against Alzheimer's disease-like characteristics in patients with Down syndrome
Read More
Ixico earns new contracts in Alzheimer's disease
Read More
EMA approves Samsung Bioepis's biosimilar etanercept Benepali
Read More
FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis
Read More
Crealta acquired by Horizon Pharma
Read More
Hinova Pharmaceuticals patents potential treatments for gout
Read More
FDA grants priority review to Eisai's lenvatinib for RCC
Read More
Pharmacyclics describes BTK inhibitors
Read More
Novartis develops sGC activators
Read More
Pfizer presents PI3Kalpha inhibitors
Read More
Lupin reports development of PI3K inhibitors
Read More
Phase III trial of isunakinra in allergic conjunctivitis misses primary endpoint
Read More
Specific tracer demonstrates favorable profile in tau pathology
Read More
Novel small-molecule Hsp90 inhibitor active in vivo in p53-related tumors
Read More
Patient in Bial clinical trial dies, another five patients stable
Read More